Treatment Of Hyperkalemia With Zs-9, A Selective Nonabsorbed Cation Exchange Resin, Does Not Lead To Hypomagnesemia: Results From Two Multicenter, Randomized, Double Blind, Placebo-Controlled Phase 3 Trials

Journal of the American College of Cardiology(2015)

引用 1|浏览13
暂无评分
摘要
Hyperkalemia (HK) limits optimal use of cardioprotective RAAS inhibitors. Treatment of HK with the non-selective cation exchanger sodium polystyrene sulfonate (SPS) has limited efficacy and is associated with adverse effects such as hypocalcemia, hypomagnesemia and colonic necrosis, which are
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要